Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Inhibition of Monoamine Oxidase by Evodiamine

Evodiamine의 Monoamine Oxidase 활성 저해작용

  • Lee, Sang-Seon (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) ;
  • Hwang, Bang-Yeon (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) ;
  • Ro, Jai-Seup (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) ;
  • Lee, Myung-Koo (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University)
  • Published : 2006.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

The effects of evodiamine on monoamine oxidase (MAO) activity were investigated. MAO was purified from mouse brain and the $K_m\;and\;V_{max}$ values of MAO were $78.5{\pm}5.28{\mu}M$ and $0.68{\pm}0.07$ nmol/min/mg protein, respectively (n=4). Evodiamine at $30-120{\mu}M$ showed an inhibitory effect on MAO activity using a substrate kynuramine with an $IC_{50}$ value of $104.2{\mu}M$ (n=4). Evodiamine also exhibited a non-competitive inhibition on MAO. The $K_i$ value for evodiamine was $72.5{\pm}10.8{\mu}M$ (n=4). These results suggest that evodiamine partially contributes to the regulation of monoamine content.

Keywords

References

  1. Hu, C. P. and Li, Y. J. (2003) Research progress in pharmacological actions of evodiamine and rutaecarpine. Chem. Pharm. Bull. 10: 1084-1087
  2. Dai, Y. Y, Liu, B. I. and Dou, C. G (2003) The pharmacological improvements of Evodia and its active components. J. Chin. Med. Mater. 4: 295-298
  3. Shoji, N., Umeyama, A., Takemoto, T., Kajiwara, A., Ohizumi, Y. (1986) Isolation of evodiamine, a powerful cardiotonic principle, from Evodia rutaecarpa Bentham (Rutaceae). J. Pharmaceut. Sci. 75: 612-613 https://doi.org/10.1002/jps.2600750619
  4. Kan, S. F., Huang, W. L., Lin, L. C. and Wang, P. S. (2004) Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int. J. Cancer 110: 641-651 https://doi.org/10.1002/ijc.20138
  5. Shyu, K. G, Lin, S., Lee, C. C, Chen, E., Lin, L. C, Wang, B. W. and Tsai, S. C. (2006) Evodiamine inhibits in vitro angiogenesis: Implication for antitumorgenicity. Life Sci. 78: 2234-2243 https://doi.org/10.1016/j.lfs.2005.09.027
  6. Nagatsu, T., Yamamoto, T. and Harada, M. (1970) Purification and properties of human brain mitochondrial monoamine oxidase. Enzymologia 39: 15-25
  7. Fowler, C. J., Ekstedt, B., Egashira, T., Kinemuchi, H. and Oreland, L. (1979) The interaction between human platelet monoamine oxidase, its monoamine substrates and oxygen. Biochem. Pharmacol. 28: 3063-3068 https://doi.org/10.1016/0006-2952(79)90614-2
  8. Houslay, M. D. and Tipton, K. F. (1976) Multiple forms of monoamine oxidase : fact and artefact. Life Sci. 19: 467-478 https://doi.org/10.1016/0024-3205(76)90224-1
  9. Donnelly, C. H. and Murphy, D. L. (1977) Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem. Pharmacol. 26: 853-858 https://doi.org/10.1016/0006-2952(77)90398-7
  10. Yang, H. Y. T. and Neff, N. H. (1974) The monoamine oxidases of brain : selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. J. Pharm. Exp. Ther. 189: 733-740
  11. Riederer, P. and Youdim, M. B. H. (1986) Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with 1-deprenyl. J. Neurochem. 46: 1359-1365 https://doi.org/10.1111/j.1471-4159.1986.tb01747.x
  12. Naoi, M. and Nagatsu, T. (1986) Quinoline and quinaldine as naturally occurring inhibitors specific for type A monoamine oxidase. Life Sci. 40: 1075-1082 https://doi.org/10.1016/0024-3205(87)90570-4
  13. Cross, A. J. and Joseph, M. H. (1981) The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection. Life Sci. 28: 499-505 https://doi.org/10.1016/0024-3205(81)90143-0
  14. Minami, M., .Maruyama, W., Dostert, P., Nagatsu, T. and Naoi, M. (1993) Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives. J. Neural Transm. 92: 125-135 https://doi.org/10.1007/BF01244872
  15. Naoi, M. and Nagatsu, T. (1988) Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds. J. Neurochem. 50: 1105-1110 https://doi.org/10.1111/j.1471-4159.1988.tb10579.x
  16. Naoi, M., Matsuura, S., Parvez, H., Takahashi, T, Hirata, Y, Minami, M. and Nagatsu, T. (1989) Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquino-linium ion by monoamine oxidase. J. Neurochem. 52: 653-655 https://doi.org/10.1111/j.1471-4159.1989.tb09170.x
  17. Naoi, M., Nomura, Y, Ishiki, R., Suzuki, H. and Nagatsu, T. (1988) 4-(O-Benzylphenoxy)-N-methylbutylamine (bife-melane) and other 4-(O-benzylphenoxy)-N-methylalky-lamines as new inhibitors of type and B monoamine oxidase. J. Neurochem. 50: 243-247 https://doi.org/10.1111/j.1471-4159.1988.tb13256.x
  18. Bembenek, M. E., Abell, C. W., Chrisey, L. A., Rozwa-dowska, M. D., Gessner, W. and Brossi, A. (1990) Inhibition of monoamine oxidase A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines. J. Med. Chem. 33: 147-152 https://doi.org/10.1021/jm00163a025
  19. Medvedev, A. E., Ivanov, A. S., Kamyshanskaya, N. S., Kirkel, A. Z., Moskvitina, T. A., Gorkin, V. Z., Li, N. Y and Marshakov, V. (1995) Interaction of indole derivatives with monoamine oxidase A and B. Studies on the structure-inhibitory activity relationship. Biochem. Mol. Biol. Int. 36: 113-122
  20. Kraml, M. (1965) A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol. 14: 1683-1685
  21. Lee, S. S., Kai, M. and Lee, M. K. (1999) Effects of natural isoquinoline alkaloids on monoamine oxidase activity in mouse brain: inhibition by berberine and palmatine. Med. Sci. Res. 27: 749-751
  22. Ro, J. S., Lee, S. S., Lee, K. S. and Lee, M. K. (2001) Inhibition of type A monoamine oxidase by coptisine in mouse brain. Life Sci. 70: 639-645 https://doi.org/10.1016/S0024-3205(01)01437-0
  23. Lee, S. S, Yun-Choi, H. S., Kim, E. I. and Lee, M. K. (1999) Inhibition of monoamine oxidase by higenamine. Med. Sci. Res. 27: 71-72
  24. Lee, S. S., Lee, J. J, Cheong, M. J., Kim, Y H., Kim, Y, Yun, Y P., Lee, C. K. and Lee, M. K. (2001) Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain. Biol. Pharm. Bull. 24: 838-840 https://doi.org/10.1248/bpb.24.838
  25. Lowry, O. H., Rosebough, N. J., Fair, A. L. and Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-267
  26. Lee, M. K, Hwang, B. Y, Lee, S. A., Oh, G J., Choi, W. H., Hong, S. S, Lee, K. S. and Ro, J. S. (2003) 1-Methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase. Chem. Pharm. Bull. 51: 409-411 https://doi.org/10.1248/cpb.51.409
  27. Severina, I. S. (1979) Mechanism of selective inhibition by clorgyline and deprenyl of the possible nature of its form A and B., in Monoamine oxidase: structure, function and altered functions, de. by Singer, T. P., Von Korff, R. W. and Murphy, D. L., 169-183, Academic Press, New York
  28. Shin, J. S., Kim, E. I, Kai, M. and Lee, M. K. (2000) Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25: 363-368 https://doi.org/10.1023/A:1007541020736
  29. Shin, J. S., Yun-Choi, H. S., Kim, E. I. and Lee, M. K. (1999) Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 65: 452-455 https://doi.org/10.1055/s-2006-960810
  30. Shin, J. S., Lee, J. J., Kim, Y, Lee, C. K., Yun, Y P. and Lee, M. K. (2001) Inhibitory effects of ethaverine, a homologue of papaverine, on dopamine content in PC12 cells. Biol. Pharm. Bull. 24: 103-105 https://doi.org/10.1248/bpb.24.103